Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Cybin IRL Limited
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Safety for Home Administration of Microdose Psilocybin Use
Johns Hopkins University
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
University of Colorado, Denver
Study of Psilocybin for Anorexia in Young Adults
Marissa Raymond-Flesch, MD, MPH
Psilocybin-assisted Treatment for Cannabis Use Disorder
Johns Hopkins University
Psilocybin for Treatment-Resistant Depression in Autism
Centre for Addiction and Mental Health
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Robin Carhart-Harris, PhD, MA
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
University Health Network, Toronto
Psilocybin in Cancer Pain Study
Yvan Beaussant, MD, MSci
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sharmin Ghaznavi
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Centre for Addiction and Mental Health
Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
University Hospital, Ghent
The Impact of Psilocybin on Pain in Fibromyalgia Patients
Maastricht University
Psilocybin in Chronic Low Back Pain and Depression
Johns Hopkins University
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
University of North Carolina, Chapel Hill
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Section for Affective Disorders; Northern Stockholm Psychiatry
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
M.D. Anderson Cancer Center
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of Calgary
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
University of California, Berkeley
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Brugmann University Hospital
Psilocybin in Functional Neurological Disorder
King's College London
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Johns Hopkins University
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin
University Health Network, Toronto
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Ottawa Hospital Research Institute
Psilocybin Therapy for Chronic Low Back Pain
Joshua Woolley, MD, PhD
Psilocybin-facilitated Treatment for Chronic Pain
University of Alabama at Birmingham
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Johns Hopkins University
Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Sunstone Medical
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Centre for Addiction and Mental Health
Psilocybin Therapy in Advanced Cancer
NYU Langone Health
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Portland VA Research Foundation, Inc
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Johns Hopkins University
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Johns Hopkins University
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
University of Wisconsin, Madison
The Neurobiological Effect of 5-HT2AR Modulation
Gitte Moos Knudsen
Safety Profile of Psilocybin for Cocaine Use Disorder
University of California, Los Angeles
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Nova Mentis Life Science Corp
Visual Surround Suppression and Perceptual Expectation Under Psilocybin
University of Minnesota
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Beckley Psytech Limited
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Usona Institute
Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Gitte Moos Knudsen
Effects of Psilocybin in Concussion Headache
Yale University
Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
Apex Labs Ltd.
Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
NWTraumatherapies
A Community of Practice Program With Psilocybin-assisted Therapy for End-of-Life Patients
The Roots to Thrive Society for Psychedelic Therapy
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.